Related Experiment Video
Updated: Jun 22, 2026

09:53
In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
Published on: July 27, 2010
16.2K
Spatial-temporal pattern of cutaneous leishmaniasis in Brazil
Tatiana P Portella1, Roberto A Kraenkel2
1Departamento de Ecologia, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil. portellatp@gmail.com.
Infectious Diseases of Poverty
|June 17, 2021
Summary
Cutaneous leishmaniasis (CL) incidence decreased overall in Brazil, but specific regions show increasing trends and emerging hotspots. Targeted surveillance and vector control are crucial for these high-risk areas.
Area of Science:
- Epidemiology
- Public Health
- Spatial Analysis
Background:
- Cutaneous leishmaniasis (CL) is a neglected tropical disease with high incidence in Brazil.
- Understanding CL spatiotemporal dynamics is vital for effective public health policies.
Purpose of the Study:
- To evaluate the spatiotemporal dynamics of CL in Brazil using statistical approaches.
- To identify high-incidence areas and changing trends of CL.
Main Methods:
- Utilized Brazilian Ministry of Health data from 2001-2017.
- Employed Mann-Kendall trend test for temporal analysis and Kuldorff scan for spatiotemporal clusters.
- Applied emerging hotspots analysis to identify and track high-risk areas.
Main Results:
- Overall CL incidence declined, but 3.2% of municipalities showed increasing trends.
- A primary cluster was identified in northern/central Brazil, with 21 secondary clusters in southern/southeastern regions.
- High spatial-temporal variability in hotspots was detected, with specific emerging and intensifying hotspots in Amazonian states and Bahia.
Conclusions:
- Statistical methods successfully identified key CL areas and temporal changes.
- Areas with permanent, new, emerging, and intensifying hotspots require focused research, surveillance, and vector control.
Related Concept Videos
Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

